Jazz Pharmaceuticals (JAZZ) Assets Average (2011 - 2026)

Jazz Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $11.8 billion for Q1 2026.

• In Q1 2026, Assets Average changed 0.12% year-over-year to $11.8 billion; the TTM figure through Mar 2026 stood at $11.8 billion (changed 0.12% YoY), while the FY2025 annual figure was $11.8 billion, up 1.14% from the prior year.
• Assets Average was $11.8 billion for Q1 2026 at Jazz Pharmaceuticals, up from $11.5 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $12.1 billion in Q4 2024 to a low of $10.6 billion in Q4 2022.
• Historically, Assets Average has averaged $11.4 billion across 5 years, with a median of $11.3 billion in 2024.
• Biggest YoY gain for Assets Average was 81.06% in 2022; the steepest drop was 15.98% in 2022.
• A 5-year view of Assets Average shows it stood at $10.6 billion in 2022, then advanced by 6.49% to $11.3 billion in 2023, then increased by 7.39% to $12.1 billion in 2024, then dropped by 5.16% to $11.5 billion in 2025, then grew by 2.19% to $11.8 billion in 2026.
• The last three Assets Average figures came in at $11.8 billion (Q1 2026), $11.5 billion (Q4 2025), and $11.2 billion (Q3 2025), per Business Quant data.